|
GTF2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.8225999999808E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.247000E-04 |
| Normal-vs-Stage2 |
4.742900E-03 |
| Normal-vs-Stage3 |
8.73490000330435E-08 |
| Normal-vs-Stage4 |
1.5372999984109E-08 |
| Stage1-vs-Stage2 |
5.532600E-01 |
| Stage1-vs-Stage3 |
7.640200E-03 |
| Stage1-vs-Stage4 |
1.363790E-03 |
| Stage2-vs-Stage3 |
2.040200E-01 |
| Stage2-vs-Stage4 |
1.228250E-01 |
| Stage3-vs-Stage4 |
5.752600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97930000001012E-06 |
| Normal-vs-AfricanAmerican |
3.376600E-03 |
| Normal-vs-Asian |
5.582200E-01 |
| Caucasian-vs-AfricanAmerican |
7.828800E-01 |
| Caucasian-vs-Asian |
4.866000E-01 |
| AfricanAmerican-vs-Asian |
6.359600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.51900000022742E-07 |
| Normal-vs-Female |
4.400700E-03 |
| Male-vs-Female |
1.755490E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.697500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.29649999999859E-05 |
| Normal-vs-Age(61-80Yrs) |
1.9108599999984E-05 |
| Normal-vs-Age(81-100Yrs) |
3.225800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.848400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.899000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.482000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.842800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.172600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.207400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.105800E-01 |
| Normal-vs-Grade 2 |
2.253600E-02 |
| Normal-vs-Grade 3 |
3.94440002882135E-09 |
| Normal-vs-Grade 4 |
1.33080000352948E-08 |
| Grade 1-vs-Grade 2 |
3.714200E-01 |
| Grade 1-vs-Grade 3 |
7.403400E-03 |
| Grade 1-vs-Grade 4 |
2.882800E-03 |
| Grade 2-vs-Grade 3 |
1.46570000003621E-06 |
| Grade 2-vs-Grade 4 |
2.47359999999697E-05 |
| Grade 3-vs-Grade 4 |
3.701600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.436500E-02 |
| Normal-vs-ccB subtype |
1.28760002660044E-09 |
| ccA subtype-vs-ccB subtype |
4.88589946279205E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.38899999996478E-06 |
| Normal-vs-N1 |
8.47010000000203E-05 |
| N0-vs-N1 |
1.118810E-01 |
|
|
